Hims & Hers Health Total Common and Preferred Stock Dividends Paid 2020-2025 | HIMS

Hims & Hers Health annual/quarterly total common and preferred stock dividends paid history and growth rate from 2020 to 2025. Total common and preferred stock dividends paid can be defined as the cash outflow for all company dividends paid out to preferred and common shareholders.
  • Hims & Hers Health total common and preferred stock dividends paid for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Hims & Hers Health total common and preferred stock dividends paid for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Hims & Hers Health annual total common and preferred stock dividends paid for 2024 were $0B, a 0% decline from 2023.
  • Hims & Hers Health annual total common and preferred stock dividends paid for 2023 were $0B, a 0% decline from 2022.
  • Hims & Hers Health annual total common and preferred stock dividends paid for 2022 were $0B, a 0% decline from 2021.
Hims & Hers Health Annual Total Common and Preferred Stock Dividends Paid
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.660B $1.477B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.506B 58.15
Tempus AI (TEM) United States $9.553B 0.00
IRhythm Technologies (IRTC) United States $4.485B 0.00
Inspire Medical Systems (INSP) United States $4.076B 63.69
Privia Health (PRVA) United States $2.775B 189.67
Enovis (ENOV) United States $1.788B 9.97
Clover Health Investments (CLOV) United States $1.598B 0.00
Schrodinger (SDGR) United States $1.586B 0.00
Phreesia (PHR) United States $1.457B 0.00
Omnicell (OMCL) United States $1.423B 25.10
Azenta (AZTA) United States $1.223B 56.85
10x Genomics (TXG) United States $1.173B 0.00
Claritev (CTEV) United States $0.632B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.593B 0.00
Talkspace (TALK) United States $0.534B 159.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.384B 0.00
TruBridge (TBRG) United States $0.360B 797.67
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00